dexamethasone sodium phosphate + isopropyl alcohol + bupivacaine hydrochloride + triamcinolone

This entry appears to describe a **nonproprietary extemporaneous combination** of two corticosteroids, a local anesthetic, and an excipient/preservative: dexamethasone sodium phosphate, triamcinolone, bupivacaine hydrochloride, and isopropyl alcohol. The provided context is dominated by labeling-style indication text for injectable corticosteroids rather than evidence for a distinct marketed or pipeline drug product containing this exact four-component combination. Pharmacologically, dexamethasone sodium phosphate and triamcinolone act as glucocorticoid receptor agonists that suppress inflammatory gene transcription and immune-cell activity, while bupivacaine blocks voltage-gated sodium channels to provide local anesthesia; isopropyl alcohol is not itself a therapeutic active ingredient in this context. Based on the available information, this is best annotated as a specific multi-ingredient pharmaceutical mixture rather than a verified branded asset, with likely use in local injection settings such as musculoskeletal or procedural pain/inflammation management, but without clear public-source evidence for a unique commercial drug identity.

Other names

dexamethasone sodium phosphate + isopropyl alcohol + bupivacaine hydrochloride + triamcinolone